Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) has received U.S. Food and Drug Administration clearance for a fully resorbable surgical mesh developed and manufactured at its Malvern facility, expanding …
TELA Bio Wins FDA Clearance for Resorbable Surgical Mesh Read More MALVERN, PA — TELA Bio Inc. (Nasdaq: TELA) plans to eliminate 41 jobs and reduce outside expenses under a restructuring expected to lower annual operating costs by $17 million as …
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position Read More MALVERN, PA — TELA Bio (Nasdaq: TELA) is cutting annual operating expenses by about $17 million and reducing its workforce by roughly 20%, a restructuring the medical technology company expects …
Malvern MedTech Cuts 20% of Staff as CFO Exits Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) withdrew its full-year 2026 revenue guidance after second-quarter sales fell 4% and its net loss widened, with newly appointed Chief Executive Officer …
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) granted newly hired Chief Executive Officer Heather Getz stock options covering 2.37 million shares and restricted stock units covering another 500,000 shares, …
TELA Bio Grants New CEO Options on 2.37 Million Shares Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) appointed Heather Getz as chief executive officer and a director effective Aug. 9, replacing co-founder Antony Koblish as the medical technology company …
TELA Bio Names Getz CEO as Founder Koblish Steps Aside Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will present at the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, providing investors with an update as the medical technology …
TELA Bio to Present at Canaccord Growth Conference Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will report second-quarter 2026 financial results on Aug. 10 and provide investors with a business update as the medical technology company continues …
TELA Bio Sets Aug. 10 Earnings Call and Business Update Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) reported modest first-quarter revenue growth as accelerating European sales helped offset slower product mix trends in the United States.
TELA Bio Expands Europe Sales as U.S. Growth Slows Read More MALVERN, PA — TELA Bio (Nasdaq: TELA) granted restricted stock units covering 89,250 shares to 12 newly hired employees as the medical device maker continues expanding its commercial operations and …
TELA Bio Expands Workforce With Nasdaq Equity Grants Read More